Home / Health / Generic Ozempic Gets Green Light

Generic Ozempic Gets Green Light

11 Apr

Summary

Orbicular Pharmaceutical received tentative approval for generic Ozempic.
Apotex Corp. will market and sell the drug in the United States.
This achievement marks a significant step for complex peptide therapies.

Orbicular Pharmaceutical Technologies has achieved a significant milestone with the tentative approval of a generic semaglutide injection, commonly known as Ozempic. This development was realized through a partnership with Apotex, with Apotex Corp. set to handle the marketing and commercialization of the product in the United States.

Orbicular's Managing Director, M. S. Mohan, highlighted the scientific rigor required for complex peptide products and commended Apotex's regulatory leadership. Barry Fishman of Apotex emphasized Orbicular's scientific expertise and commitment to quality in advancing affordable peptide therapies for patients.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.